Yinghui Yuan

机构：Hangzhou Normal University, Hangzhou Hospital of Traditional Chinese Medicine

发表论文 9 篇 · 总被引 208 次 · h-index 6

代表论文

• Design, Synthesis, and Structure–Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition (2024 · Journal of Medicinal Chemistry · 被引 65)
• Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β -elemene scaffold (2023 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 59)
• Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR) (2022 · Molecules · 被引 23)
• Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents (2023 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 21)
• Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment (2024 · Journal of Medicinal Chemistry · 被引 19)
• A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase (2025 · Biochemical Pharmacology · 被引 9)